Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism.

Laje P, Halaby L, Adzick NS, Stanley CA.

Pediatr Diabetes. 2010 Mar;11(2):142-7. doi: 10.1111/j.1399-5448.2009.00547.x. Epub 2009 Jun 25. Review.

PMID:
19558634
2.

[Octreotide therapy for persistent hyperinsulinemic hypoglycemia of infancy].

Ferraz DP, Almeida MA, Mello BF.

Arq Bras Endocrinol Metabol. 2005 Jun;49(3):460-7. Epub 2006 Mar 16. Review. Portuguese.

3.

Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).

Hussain K, Aynsley-Green A, Stanley CA.

Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:163-7. Review.

PMID:
16456495
4.

Octreotide.

Stajich GV, Ashworth L.

Neonatal Netw. 2006 Sep-Oct;25(5):365-9. Review.

PMID:
16989134
5.

Octreotide in the treatment of congenital chylothorax.

Rasiah SV, Oei J, Lui K.

J Paediatr Child Health. 2004 Sep-Oct;40(9-10):585-8. Review.

PMID:
15367160
6.

Octreotide in hyperinsulinism.

Barrons RW.

Ann Pharmacother. 1997 Feb;31(2):239-41. Review.

PMID:
9034427
7.

Surgical management of congenital hyperinsulinism of infancy.

Pierro A, Nah SA.

Semin Pediatr Surg. 2011 Feb;20(1):50-3. doi: 10.1053/j.sempedsurg.2010.10.009. Review.

PMID:
21186005
8.

Neonatal necrotizing enterocolitis: a focus on.

Pellegrini M, Lagrasta N, Garcìa Garcìa C, Campos Serna J, Zicari E, Marzocca G.

Eur Rev Med Pharmacol Sci. 2002 Jan-Feb;6(1):19-25. Review.

PMID:
12608653
9.

Persistent hyperinsulinemic hypoglycemia of infancy: long-term results.

Dacou-Voutetakis C, Psychou F, Maniati-Christidis M.

J Pediatr Endocrinol Metab. 1998 Mar;11 Suppl 1:131-41. Review.

PMID:
9642651
10.

Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.

De León DD, Stanley CA.

Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):57-68. Review.

PMID:
17179930
12.

Surgical versus non-surgical treatment of congenital hyperinsulinism.

Mazor-Aronovitch K, Landau H, Gillis D.

Pediatr Endocrinol Rev. 2009 Mar;6(3):424-30. Review.

PMID:
19396028
13.

Debut of a somatostatin analog: octreotide in review.

Zindel LR.

Conn Med. 1989 Dec;53(12):741-4. Review.

PMID:
2558839
14.

Spontaneous neonatal chylothorax treated with octreotide.

Siu SL, Lam DS.

J Paediatr Child Health. 2006 Jan-Feb;42(1-2):65-7. Review.

PMID:
16487393
15.

Octreotide and enterocutaneous fistula closure in neonates and children.

Carrera-Guermeur N, Martín-Crespo RM, Ramírez HJ, Pantoja Á, Luque-Mialdea R.

Eur J Pediatr. 2016 Mar;175(3):305-12. doi: 10.1007/s00431-016-2693-y. Epub 2016 Jan 26. Review.

PMID:
26811298
16.

Endogenous hyperinsulinism: diagnosis, management, and long-term follow-up.

Shilyansky J, Cutz E, Filler RM.

Semin Pediatr Surg. 1997 Aug;6(3):115-20. Review.

PMID:
9263332
17.

Inhibitors of gastric acid secretion drugs increase neonatal morbidity and mortality.

Terrin G, Canani RB, Passariello A, Caoci S, De Curtis M.

J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:85-7. doi: 10.3109/14767058.2012.714975. Review.

PMID:
22958029
18.

Octreotide.

Murphy E, Prommer EE, Mihalyo M, Wilcock A.

J Pain Symptom Manage. 2010 Jul;40(1):142-8. Review. No abstract available.

PMID:
21634046
19.

Management strategies for neonatal hypoglycemia.

Sweet CB, Grayson S, Polak M.

J Pediatr Pharmacol Ther. 2013 Jul;18(3):199-208. doi: 10.5863/1551-6776-18.3.199. Review.

20.

OCTREOTIDE IN GASTROENTEROLOGY.

Chaudhry R, Singh B, Subhas P.

Med J Armed Forces India. 1997 Oct;53(4):293-294. doi: 10.1016/S0377-1237(17)30757-8. Epub 2017 Jun 26. Review. No abstract available.

Supplemental Content

Support Center